Literature DB >> 7486554

Does immunological tolerance explain the waste in the B-lymphocyte immune system? Experiment and theory.

D Nemazee1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7486554     DOI： 10.1111/j.1749-6632.1995.tb55854.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

2.  B-cell-targeted therapy for the fibrotic complications of systemic sclerosis.

Authors:  Robert Woodrick; John Varga
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 3.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 4.  B cells in chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Bruce R Blazar; Corey Cutler; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-12       Impact factor: 5.742

5.  Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.

Authors:  Isabelle Isnardi; Yen-Shing Ng; Laurence Menard; Greta Meyers; David Saadoun; Iva Srdanovic; Jonathan Samuels; Jessica Berman; Jane H Buckner; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  Blood       Date:  2010-03-15       Impact factor: 22.113

Review 6.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

Review 7.  B-cell survival factors in autoimmune rheumatic disorders.

Authors:  Sandra A Morais; Andreia Vilas-Boas; David A Isenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

Review 8.  Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.

Authors:  Eric Meffre; Kevin C O'Connor
Journal:  Immunol Rev       Date:  2019-11-12       Impact factor: 10.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.